Issue: October 2017
October 09, 2017
1 min read
Save

Trial Scorecard: VALIDATE-SWEDEHEART

Issue: October 2017
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Comparison of bivalirudin and heparin alone in patients with non-STEMI or STEMI undergoing PCI.

Trial Scorecard: VALIDATE-SWEDEHEART